Dr. Maggie De Block:

In Germany they have another system. When there is EMA approval, it is reimbursed immediately after a month, I believe. After a year, Germany re-evaluates if the drug will be reimbursed and under what price that would happen if it continues. That is one way. The current minister is also looking for a shorter way and we are also looking at systems in other countries. We cannot do what they do in Netherlands because we do not have the private partners that decide what to pay for the drug. We are looking at the German example, and that would shorten by a lot the period for reimbursement. Everyone is searching for the miracle procedure.